Document is current
Any future updates will be listed below
-
Authors
Jones, Ross D. https://orcid.org/0000-0003-0891-6761
Qian, Yili https://orcid.org/0000-0002-1097-0401
Siciliano, Velia https://orcid.org/0000-0001-7734-9153
DiAndreth, Breanna https://orcid.org/0000-0002-0302-6834
Huh, Jin
Weiss, Ron https://orcid.org/0000-0003-0396-2443
Del Vecchio, Domitilla https://orcid.org/0000-0001-6472-8576
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (NIH P50GM098792, NIH P50GM098792, NIH P50GM098792, NIH P50GM098792, NIH P50GM098792)
National Science Foundation (MCB-1840257, MCB-1840257, MCB-1840257)
United States Department of Defense | United States Air Force | AFMC | Air Force Office of Scientific Research (FA9550-14-1-0060, FA9550-14-1-0060)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 8 July 2020
Accepted: 18 September 2020
First Online: 10 November 2020
Competing interests
: The Massachusetts Institute of Technology has filed a patent application on behalf the inventors (R.D.J., Y.Q., B.D., R.W., and D.D.V.) of the endoRNase-based iFFL design described (US Provisional Application No. 62/992,82). The remaining authors declare no competing interests.
